Recombinant Anti-EGFR x Anti-IGF1R Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-EGFR antibody are both extended with the scFv fragment from an anti-IGF1R antibody. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Colorectal cancer; Cervical cancer; Breast cancer; Pancreatic cancer therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-EGFR x Anti-IGF1R Bispecific Antibody (Triple Body) (TRIB-H325). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS